Biden administration asks Pfizer, Moderna and Novavax for ‘reasonable’ prices on updated Covid vaccines

PUBLISHED THU, JUL 13 202312:43 PM EDT UPDATED THU, JUL 13 20236:57 PM EDT

By: Annika Kim Constantino

KEY POINTS

  • The Biden administration urged Pfizer, Moderna and Novavax to price their updated Covid vaccines at a “reasonable” rate when they roll them out in the U.S. this fall.
  • None of the three manufacturers have disclosed the exact pricing of their single-strain vaccines, which are being designed to target the circulating omicron subvariant XBB.1.5. 
  • The price points for the shots will be crucial in the fall, as the federal government is expected to shift Covid vaccine distribution to the commercial market.

Read more here

Facebook
Twitter
LinkedIn
Skip to content